SPRY2 and neoplasm: Conversely, gain of cg16766325 methylation in the promoter region of SPRY2, a tumor suppressor with endogenous inhibitory activity for the RAS/MAPK pathway, was associated with decreased SPRY2 mRNA expression (Supplemental Figure 4E).